Sequencing of two HLA-A blank alleles: Implications in unrelated bone marrow donor matching

Transplantation

Volumn 67, Issue 10, 1999, Pages 1336-1341

  Zanone Ramseier, Rachel ^a   Gratwohl, Aloïs ^b   Gmür, Jürg ^c   Roosnek, Eddy ^a   Tiercy, Jean Marie ^a  

^a Hôpital Cantonal   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Division of Hematology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; MESSENGER RNA;

ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; GENE EXPRESSION; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY;

ALLELES; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HUMANS; LEUKEMIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033609330     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905270-00008     Document Type: Article

References (26)

1. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system 1996. Tissue Antigens 1997; 49: 297.
2. Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP. 5′ regulatory sequence of an HLA-A*0101 null allele. Immunogenetics 1997; 46; 152.
3. Balas A, Garcia-Sanchez F, Gomez-Reino F, Vicario JL. HLA class I allele (HLA-A2) expression defect associated with a mutation in its enhancer B inverted cat box in two families. Human Immunol 1994; 41: 69.
4. Lienert K, Russ G, Lester S, Bennett G, Gao X, McCluskey J. Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. Tissue Antigens 1996; 48: 187.
5. Ishikawa Y, Tokunaga K, Tanaka H, et al. HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult. Immunogenetics 1995; 43: 1.
6. Magor KE, Taylor EJ, Shen SY, et al. Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol 1997; 158: 5242.
7. Blasczyk R, Rebman V, Grosse-Wilde H. A second HLA-B null allele. Eur J Immunogenet 1998; 25 (Suppl 1): 7.
8. Laforet M, Froelich N, Parissiadis A, Bausiegr H, Pfeiffer B, Tongio M-M. An intronic mutation responsible for a low level of expression of an HLA-A*24 allele. Tissue Antigens 1997; 50: 340.
9. Tonks S, Marsh SGE, Bunce M, et al. HLA class I DNA typing study In: Charron D, ed. Proceedings of the 12th International Histocompatibility Workshop and Conference. EDK Publisher, Paris, 1997; 1: 199.
10. Tiercy J-M, Djavad N, Rufer N, Speiser D, Jeannet M, Roosnek E. Oligotyping of HLA-A2, -A3, and -B44 subtypes: detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Immunol 1994; 41: 207.
11. Gauchat-Feiss D, Rufer D, Speiser D, Jeannet M, Roosnek E, Tiercy J-M. Heterogeneity of HLA-B35: oligotyping and direct sequencing for B35 subtypes reveals a high mismatching rate in B35 serologically compatible kidney and bone marrow donor/recipient pairs. Transplantation 1995; 60: 869.
12. Grundschober C, Rufer N, Sanchez-Mazas A, et al. Molecular characterization of HLA-C incompatibilities in HLA-ABDR matched unrelated bone marrow donor/recipient pairs: sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes. Tissue Antigens 1997; 49: 612.
13. Zemmour J, Little A-M, Schendel D, Parham P. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 1992; 148: 1941.
14. Curran MD, Williams F, Earle JAP, et al. Long-range PCR amplification as an alternative strategy for characterizing novel HLA-B alleles. Eur J Immunogenet 1996; 23: 297.
15. Cereb N, Maye P, Lee S, Kong Y, Yang SY. Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens 1995; 45: 1.
16. Cereb N, Yang SY. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation. J Immunol 1994; 152: 3873.
17. Krausa P, Bodmer JG, Browning MJ. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 1994; 42: 91.
18. Rufer N, Tiercy J-M, Breur-Vriesendorp B, et al. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995; 16: 641.
19. Laforet M, Froelich N, Parissiadis A, et al. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. Tissue Antigens 1997; 50: 347.
20. Cereb N, Kong Y, Lee S, Maye P, Yang SY. Nucleotide sequences of MHC class I introns 1, 2, and 3 in humans and intron 2 in nonhuman primates. Tissue Antigens 1996; 47: 498.
21. Bunce M, Barnardo MCNM, Procter J, Marsh SGE, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 1996; 48: 680.
22. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low level of HLA-C expression at cell surface correlates with increased turnover of heavy chain mRNA. J Exp Med 1995; 181: 2085.
23. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221.
24. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
25. Vella JP, Spadafora-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
26. Ciubotariu R, Liu Z, Colovai AI, et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398.